Alzheimer’s Disease – Diagnosis and Treatment
Overview
Affiliations
Alzheimer's disease is the most common cause of dementia globally. Its prevalence will increase considerably in the years to come, in pace with the increasing proportion of older people. No disease-modifying treatment is currently available. Measures to mitigate risk in mid-life may potentially prevent or postpone up to 40 % of dementia cases at group level.
Non-Invasive Retinal Biomarkers for Early Diagnosis of Alzheimer's Disease.
Kastelan S, Gverovic Antunica A, Puzovic V, Didovic Pavicic A, canovic S, Kovacevic P Biomedicines. 2025; 13(2).
PMID: 40002697 PMC: 11852429. DOI: 10.3390/biomedicines13020283.
Glycosylation in aging and neurodegenerative diseases.
Zhang W, Chen T, Zhao H, Ren S Acta Biochim Biophys Sin (Shanghai). 2024; 56(8):1208-1220.
PMID: 39225075 PMC: 11466714. DOI: 10.3724/abbs.2024136.
Potential Application of MicroRNAs and Some Other Molecular Biomarkers in Alzheimer's Disease.
Paprzycka O, Wieczorek J, Nowak I, Madej M, Strzalka-Mrozik B Curr Issues Mol Biol. 2024; 46(6):5066-5084.
PMID: 38920976 PMC: 11202417. DOI: 10.3390/cimb46060304.
Li R, Yao S, Wei F, Chen M, Zhong Y, Zou C Sci Rep. 2024; 14(1):11487.
PMID: 38769091 PMC: 11106282. DOI: 10.1038/s41598-024-62347-x.
Zhou L, Huang X, Li H, Wang J, Lu Z Exp Ther Med. 2023; 26(3):440.
PMID: 37614428 PMC: 10443046. DOI: 10.3892/etm.2023.12139.